Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 1,011,000 | reported | 07 May 2026 | tx 8+362,900−621,352 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | SALE | Atara Biotherapeutics, Inc. | 313,446 | 10.10 USD | |
| 17 Mar 2026 | EXERCISE | Atara Biotherapeutics, Inc. | 259,163 | 0.00 USD | |
| 17 Mar 2026 | TAX_WITHHOLDING | Atara Biotherapeutics, Inc. | 5 | 5.23 USD | |
| 17 Mar 2026 | EXERCISE | Atara Biotherapeutics, Inc. | 259,163 | 6.61 USD | deriv |
| 28 Nov 2025 | TAX_WITHHOLDING | Atara Biotherapeutics, Inc. | 1 | 14.03 USD | |
| 28 Nov 2025 | EXERCISE | Atara Biotherapeutics, Inc. | 48,737 | 0.00 USD | |
| 28 Nov 2025 | EXERCISE | Atara Biotherapeutics, Inc. | 48,737 | 6.61 USD | deriv |
| 15 Aug 2025 | PURCHASE | Atara Biotherapeutics, Inc. | 55,000 | 12.19 USD |